Literature DB >> 17478163

Relation between mitral annular calcium and complex aortic atheroma in patients with cerebral ischemia referred for transesophageal echocardiography.

Maria G Karas1, Steven Francescone, Alan Z Segal, Richard B Devereux, Mary J Roman, Jennifer E Liu, Rebecca T Hahn, Jorge R Kizer.   

Abstract

Mitral annular calcium (MAC) has been shown to be an independent predictor of stroke, but the basis for this association remains incompletely defined. This study was conducted to investigate the extent to which aortogenic embolism may mediate the MAC-stroke relation. In a cross-sectional study of patients referred for transesophageal echocardiography for the evaluation of cerebral ischemia, the relation between MAC and proximal and distal complex aortic atheroma (CAA) was assessed. In 419 patients composing the study cohort, MAC was associated with atherosclerosis risk factors, previous cardiovascular disease, atrial fibrillation, ipsilateral large-artery stenosis, left-sided cardiac abnormalities, and aortic valve calcium. MAC was associated with CAA of the proximal and distal thoracic aorta in unadjusted analyses, and these associations became stronger with increasing MAC severity. After adjustment for clinical and echocardiographic covariates, MAC exhibited a significant association with proximal and distal CAA in the entire cohort. In patients without alternative potential mechanisms for cerebral ischemia, however, the relation with proximal CAA became more pronounced (adjusted odds ratio 2.74, 95% confidence interval 1.22 to 6.16), but that for distal CAA changed little and became nonsignificant (adjusted odds ratio 1.97, 95% confidence interval 0.87 to 4.45). In conclusion, MAC was significantly associated with proximal and distal CAA independent of clinical and echocardiographic covariates in this cohort with cerebral ischemia, but in subjects without identifiable alternative mechanisms, the magnitude of the relation increased only for proximal CAA. These findings support the role of proximal CAA as a direct mediator of the increased stroke risk associated with MAC.

Entities:  

Mesh:

Year:  2007        PMID: 17478163      PMCID: PMC1892237          DOI: 10.1016/j.amjcard.2006.12.053

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  24 in total

Review 1.  Aortic atherosclerotic disease and stroke.

Authors:  Itzhak Kronzon; Paul A Tunick
Journal:  Circulation       Date:  2006-07-04       Impact factor: 29.690

2.  The prevalence of ulcerated plaques in the aortic arch in patients with stroke.

Authors:  P Amarenco; C Duyckaerts; C Tzourio; D Hénin; M G Bousser; J J Hauw
Journal:  N Engl J Med       Date:  1992-01-23       Impact factor: 91.245

3.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

4.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

Authors:  R B Devereux; D R Alonso; E M Lutas; G J Gottlieb; E Campo; I Sachs; N Reichek
Journal:  Am J Cardiol       Date:  1986-02-15       Impact factor: 2.778

5.  Bacterial endocarditis on calcification of the mitral anulus fibrosus.

Authors:  J W Burnside; R W Desanctis
Journal:  Ann Intern Med       Date:  1972-04       Impact factor: 25.391

6.  Association between large aortic arch atheromas and high-intensity transient signals in elderly stroke patients.

Authors:  T Rundek; M R Di Tullio; R R Sciacca; I V Titova; J P Mohr; S Homma; R L Sacco
Journal:  Stroke       Date:  1999-12       Impact factor: 7.914

7.  Mitral annulus calcification with a mobile component as a possible source of embolism.

Authors:  R Shohat-Zabarski; R Paz; Y Adler; M Vaturi; R Jortner; A Sagie
Journal:  Am J Geriatr Cardiol       Date:  2001 Jul-Aug

8.  Relation of various degrees of body mass index in patients with systemic hypertension to left ventricular mass, cardiac output, and peripheral resistance (The Hypertension Genetic Epidemiology Network Study).

Authors:  V Palmieri; G de Simone; D K Arnett; J N Bella; D W Kitzman; A Oberman; P N Hopkins; M A Province; R B Devereux
Journal:  Am J Cardiol       Date:  2001-11-15       Impact factor: 2.778

9.  Racial differences in the prevalence of cardiac sources of embolism in subjects with unexplained stroke or transient ischemic attack evaluated by transesophageal echocardiography.

Authors:  Jorge R Kizer; Frank E Silvestry; Stephen E Kimmel; Scott E Kasner; Susan E Wiegers; Michael B Erwin; Stephanie A Schwalm; Mohan N Viswanathan; John R Pollard; Martin G Keane; Martin G St John Sutton
Journal:  Am J Cardiol       Date:  2002-08-15       Impact factor: 2.778

10.  Protruding atheromas in the thoracic aorta and systemic embolization.

Authors:  P A Tunick; J L Perez; I Kronzon
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

View more
  3 in total

1.  LV thrombus detection by routine echocardiography: insights into performance characteristics using delayed enhancement CMR.

Authors:  Jonathan W Weinsaft; Han W Kim; Anna Lisa Crowley; Igor Klem; Chetan Shenoy; Lowie Van Assche; Rhoda Brosnan; Dipan J Shah; Eric J Velazquez; Michele Parker; Robert M Judd; Raymond J Kim
Journal:  JACC Cardiovasc Imaging       Date:  2011-07

2.  Association of annular calcification and aortic valve sclerosis with brain findings on magnetic resonance imaging in community dwelling older adults: the cardiovascular health study.

Authors:  Carlos J Rodriguez; Traci M Bartz; W T Longstreth; Jorge R Kizer; Eddy Barasch; Donald M Lloyd-Jones; John S Gottdiener
Journal:  J Am Coll Cardiol       Date:  2011-05-24       Impact factor: 24.094

3.  Mitral annular calcification is associated with atrial fibrillation and major cardiac adverse events in atrial fibrillation patients: A systematic review and meta-analysis.

Authors:  Yimin Li; Zhiping Lu; Xiangyu Li; Jin Huang; Qinghua Wu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.